PALO ALTO VETERANS INSTITUTE FOR RESEARCH: Form 990, tax year 2024
View the entire original 990 at ProPublica ↗
- Organization
- PALO ALTO VETERANS INSTITUTE FOR RESEARCH (EIN 77-0207331)
- Tax period
- 2024-10-01 to 2025-09-30
- Filed
- 2026-06-01
- IRS object ID
- 202621529349301322
- Schema version
- 2024v5.5
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-06-01T15:42:27-05:00 | ReturnTs |
| Tax Period End | 2025-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 390859910 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BAKER TILLY ADVISORY GROUP LP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 333 BUSH STREET STE 1000 | AddressLine1Txt |
| City | SAN FRANCISCO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94104 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2024-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 770207331 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PALO ALTO VETERANS INSTITUTE FOR | BusinessNameLine1Txt |
| Business Name Line2 | RESEARCH | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | PALO | BusinessNameControlTxt |
| Phone | 6502392800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3801 MIRANDA AVENUE | AddressLine1Txt |
| City | PALO ALTO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 943040038 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | ELAINE STAATS | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Phone | 6502392800 | PhoneNum |
| Signature | 2026-06-01 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | MICHAEL LUMSDEN | PreparerPersonNm |
| PTIN | P01262236 | PTIN |
| Phone | 4159561500 | PhoneNum |
| Preparation | 2026-06-01 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2024 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PAVIR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | ELAINE STAATS MPH | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3801 MIRANDA AVENUE | AddressLine1Txt |
| City | PALO ALTO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 943040038 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $35,854,131 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.PAVIR.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1988 | FormationYr |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Activity Or Mission | PAVIR'S MISSION IS TO ADVANCE VETERAN HEALTH AND PUBLIC HEALTH THROUGH INNOVATION RESEARCH. PAVIR WORKS WITH MORE THAN 100 PRINCIPAL INVESTIGATORS, BOTH CLINICIAN SCIENTISTS WHOSE TIME IS DIVIDED BETWEEN PATIENT CARE AND RESEARCH, AND THOSE WHOSE SOLE RESPONSIBILITY IS RESEARCH, AT THE VA PALO ALTO HEALTH CARE SYSTEM (VAPAHCS). THIS VA RESEARCH INCLUDES NOT ONLY CLINICAL RESEARCH, BUT BASIC SCIENCE INVESTIGATING DISEASE MECHANISMS IN THE LABORATORY AS WELL AS DATA DRIVEN HEALTH SERVICES RESEARCH DEVELOPING IMPROVED MODELS OF HEALTH CARE DELIVERY. VA RESEARCH ADDRESSES HEALTH CHALLENGES ESPECIALLY PREVALENT IN VETERANS, INCLUDING POST-TRAUMATIC STRESS DISORDER (PTSD), TRAUMATIC BRAIN INJURY (TBI), GERIATRIC MEDICINE AND POLYTRAUMA AS WELL AS OTHER PUBLIC HEALTH ISSUES. RESEARCHERS HAVE APPOINTMENTS AT VAPAHCS, AND MOST ALSO HOLD FACULTY APPOINTMENTS AT THE STANFORD UNIVERSITY SCHOOL OF MEDICINE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 13 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 3 | VotingMembersIndependentCnt |
| Total Employee | 203 | TotalEmployeeCnt |
| Total Volunteers | 7 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $23,286,921 | PYContributionsGrantsAmt |
| CY Contributions Grants | $25,318,301 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $7,728,039 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $10,144,436 | CYProgramServiceRevenueAmt |
| PY Investment Income | $602,254 | PYInvestmentIncomeAmt |
| CY Investment Income | $367,884 | CYInvestmentIncomeAmt |
| PY Other Revenue | $29,413 | PYOtherRevenueAmt |
| CY Other Revenue | $23,510 | CYOtherRevenueAmt |
| PY Total Revenue | $31,646,627 | PYTotalRevenueAmt |
| CY Total Revenue | $35,854,131 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $18,983,304 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $19,815,713 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $15,371,897 | PYOtherExpensesAmt |
| CY Other Expenses | $13,213,675 | CYOtherExpensesAmt |
| PY Total Expenses | $34,355,201 | PYTotalExpensesAmt |
| CY Total Expenses | $33,029,388 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$2,708,574 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $2,824,743 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $17,246,189 | TotalAssetsBOYAmt |
| Total Assets EOY | $19,146,651 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $12,030,150 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $11,109,618 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $5,216,039 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $8,037,033 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | PAVIR'S MISSION IS ADVANCING VETERANS AND PUBLIC HEALTH THROUGH INNOVATIVE RESEARCH. PAVIR WORKS WITH MORE THAN 100 PRINCIPAL INVESTIGATORS AND 200 RESEARCH STAFF TO SUPPORT BASIC SCIENCE, CLINICAL AND HEALTH SERVICES RESEARCH TO REALIZE ITS MISSION. PAVIR'S DIVERSE STUDIES SPAN THE ENTIRE SPECTRUM OF HEALTH RESEARCH FROM THE INVESTIGATION OF DISEASES IN THE LABORATORY THROUGH TESTING NEW DRUG TREATMENTS AND DEVELOPING IMPROVED MODELS OF HEALTH CARE DELIVERY TO LOOKING AT OUTCOMES BOTH INDIVIDUALLY AND ON A LARGE SCALE. PAVIR'S RESEARCH ADDRESSES HEALTH CHALLENGES THAT HAVE BEEN FACED ESPECIALLY BY VETERANS, INCLUDING POST-TRAUMATIC STRESS DISORDER, TRAUMATIC BRAIN INJURY, GERIATRIC MEDICINE, REHABILITATION, SLEEP AND OTHER VETERANS AND PUBLIC HEALTH ISSUES. PAVIR'S INVESTIGATORS HAVE APPOINTMENTS AT THE VA PALO ALTO HEALTH CARE SYSTEM AND MOST ALSO HOLD APPOINTMENTS AT THE STANFORD UNIVERSITY SCHOOL OF MEDICINE. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $1,310,697 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | CLINICAL TRANSLATION OF ALLOGENEIC REGENERATIVE CELL THERAPY FOR WHITE MATTER STROKE AND VASCULAR DEMENTIA. PRINCIPAL INVESTIGATOR: IRENE LORENZO LLORENTE, PH.D.STROKE IS THE LEADING CAUSE OF ADULT DISABILITY AND THE SECOND LEADING CAUSE OF DEMENTIA. WHITE MATTER STROKE (WMS) CONSTITUTES UP TO 30% OF ALL STROKE SUBTYPES AND IS A DISTINCT PROCESS FROM "LARGE ARTERY STROKE." WMS BEGINS AS SMALL INFARCTS IN DEEP PENETRATING BLOOD VESSELS IN THE BRAIN BUT PROGRESSES, ACCUMULATES, AND EXPANDS FROM PREEXISTING LESIONS INTO ADJACENT WHITE MATTER TO PRODUCE HEMIPARESIS WITH INCOMPLETE RECOVERY, GAIT ABNORMALITIES, COGNITIVE DECLINE, AND EXECUTIVE DYSFUNCTION CHARACTERISTIC OF VASCULAR DEMENTIA (VAD). UNLIKE LARGE ARTERY STROKE, WMS DOES NOT DAMAGE NEURONAL CELL BODIES BUT PRIMARILY AFFECTS AXONAL TRACTS AND GLIAL CELLS. A CELL-BASED THERAPY CAPABLE OF REPLACING LOST GLIA AND INDUCING STRUCTURAL REPAIR IN WMS/VAD HOLDS GREAT PROMISE. WE HAVE DEVELOPED A UNIQUE ALLOGENEIC HUMAN INDUCED PLURIPOTENT STEM CELL (HIPSC)-DERIVED GLIAL ENRICHED PROGENITOR (GEP) CELL THERAPY PRODUCT FOR THE TREATMENT OF WMS AND VAD. PRECLINICAL STUDIES DEMONSTRATE THAT HIPSC-GEPS TRANSPLANTED INTO THE BRAIN AFTER WMS/VAD PROMOTE MOTOR AND COGNITIVE RECOVERY THROUGH MULTIPLE MECHANISMS OF ACTION, INCLUDING AXONAL GROWTH, ASTROCYTIC MODULATION, OLIGODENDROCYTE DIFFERENTIATION, AND REMYELINATION. THIS YEAR, WE ACHIEVED A SUCCESSFUL PRE-IND MEETING WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR GEP-101 (HIPSC-GEPS) ON FEBRUARY 26, 2026. THE DISCUSSION, INFORMED BY THE FDA'S PRELIMINARY WRITTEN RESPONSES DATED FEBRUARY 23, 2026, FOCUSED ON FOUR PRIMARY AREAS: (1) SUITABILITY OF THE HIPSC CELL LINE AND DONOR ELIGIBILITY TESTING, (2) ADEQUACY OF THE PROPOSED CLINICAL DELIVERY DEVICE AND ADDITIONAL NONCLINICAL EVALUATION NEEDS, (3) REQUIREMENTS FOR DEVICE COMPATIBILITY TESTING TO ENSURE PRODUCT QUALITY AND DOSE ACCURACY, AND (4) QUALIFICATION OF CERTAIN MANUFACTURING RAW MATERIALS, INCLUDING THE VEEV RNA REPLICON USED DURING CELL REPROGRAMMING. OVERALL, THE FDA AGREED WITH ALL POSITIONS PRESENTED, CLARIFYING EXPECTATIONS FOR MANUFACTURING CONTROLS, DEVICE USE, AND SUPPORTING NONCLINICAL DATA PRIOR TO IND SUBMISSION.FOLLOWING THE PRE-IND MEETING, WE HAVE SUBMITTED A NEW GRANT PROPOSAL TO SECURE THE NEXT ROUND OF FUNDING AND CONTINUE ADVANCING TOWARD IND APPROVAL AND FUTURE CLINICAL TRANSLATION. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,238,218 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | NOVEL LYMPHOCYTE CHEMOATTRACTANT RECEPTOR AND LIGAND. PRINCIPAL INVESTIGATOR: EUGENE BUTCHER, M.D.WE HAVE IDENTIFIED A NOVEL LYMPHOCYTE CHEMOATTRACTANT RECEPTOR AND ITS CHEMOATTRACTANT LIGAND, SELECTIVELY EXPRESSED IN LUNG, AIRWAYS, UPPER GI TRACT, GENITOURINARY MUCOSAE AND MUCOSA-ASSOCIATED GLANDS INCLUDING THE PANCREAS AND SALIVARY GLANDS. AIM 1: WE WILL MECHANISTICALLY PROBE THE RECEPTOR-LIGAND INTERACTIONS FOCUSING ON THE SPECIFICITY AND SIGNALING PATHWAYS ACTIVATED BY THE NOVEL RECEPTOR AND ITS ROLE AS A LYMPHOCYTE VS MYELOID CELL CHEMOTACTIC RECEPTOR. STRUCTURE-FUNCTION STUDIES WILL IDENTIFY LIGAND DOMAINS FOR RECEPTOR BINDING AND ACTIVATION. AIM 2: WILL DEFINE THE REGULATION OF THE RECEPTOR IN THE MOUSE, AND ITS ROLE IN LYMPHOCYTE POPULATION OF AND HOMING TO NON-LYMPHOID TISSUES DURING HOMEOSTASIS AND IN THE SETTING OF CHRONIC MULTI-ORGAN AUTOIMMUNE INFLAMMATION. THE ROLES OF THE PATHWAY IN IMMUNE CELL DEVELOPMENT WILL BE PROBED IN MIXED BONE MARROW CHIMERAS IN WHICH RECEPTOR-DEFICIENT VS WILD TYPE STEM CELLS COMPETE FOR RECONSTITUTION OF IMMUNE COMPARTMENTS IN LYMPHOID AND NON-LYMPHOID TISSUES. AIM 3: WILL ELUCIDATE THE TISSUE- AND CELL SUBSET-SPECIFIC EXPRESSION OF THE RECEPTOR AND LIGAND IN HUMANS.WHILE MUCH OF AIM 1 HAS BEEN COMPLETED AND PRESENTED IN OUR NATURE PUBLICATION, THIS AIM AS WELL AS THE GRANT AS A WHOLE HAS AS ITS OVERARCHING GOAL TO IDENTIFY AND CHARACTERIZE THE GPCR INTERACTIONS AND FUNCTIONS OF CXCL17. OUR ALPHA FOLD MODELING SUPPORTED OUR INITIAL CHARACTERIZATION OF CXCL17-GPR25 INTERACTION. USING THIS AS A JUMPING OFF POINT, WE ARE ASKING WHETHER IN SILICO MODELING IN SCREENING MODE CAN IDENTIFY THE FUNCTIONAL GPCR LIGANDS OF CXCL17 (AND THUS POTENTIALLY OF OTHER ORPHAN CHEMOKINES). IN HIGH THROUGHPUT SCREENING MODE, WE GENERATED AF2 MODELS OF CXCL17 INTERACTIONS WITH ALL CLASS A GPCRS AND FIND THAT THE HIGHEST SCORING MODELS INCLUDE GPR25 BUT ALSO TWO OTHER RECEPTORS: BDKRB1, THE INFLAMMATION ASSOCIATED BRADYKININ RECEPTOR, AND NTSR2, THE NEUROTENSIN RECEPTOR. OTHER RECEPTORS SHOWED NO OR UNFAVORABLE INTERACTIONS (DEFINED BY AF2 METRICS INCLUDING IPTM ON LIGAND AND RECEPTOR RESIDUES INTERACTING IN THE LIGAND BIND POCKET OF THE GPCR). THESE IN SILICO FINDINGS SUGGEST THE POSSIBILITY OF ADDITIONAL RECEPTORS FOR CXCL17 THAT COULD IMPACT VASCULAR AND NEUROBIOLOGY. A MAJOR FOCUS THIS YEAR IN REGARDS TO AIM 2 HAS BEEN ON EXPANDING AND INITIALLY CHARACTERIZING GPR25 DEFICIENT MICE, TO DEFINE THE ROLE OF GPR25 IN LYMPHOCYTE SUBSET REPRESENTATION AND DISTRIBUTION IN MUCOSAL TISSUES. WE HAVE ESTABLISHED THE COLONY AND HAVE EVALUATED BASAL LYMPHOCYTE SUBSETS IN THE RESTING STATE. THE RESULTS LARGELY PARALLEL THOSE IN CXCL17 DEFICIENT MICE, INDICATING THAT CXCL17 IS LIKELY THE ONLY OR THE PREDOMINANT CHEMOKINE LIGAND FOR GPR25. WE HAVE GENERATED MIXED (WT/KO) BONE MARROW CHIMERAS TO DEFINE THE EFFECT OF GPR25 DEFICIENCY BY EVALUATING KO LYMPHOCYTE REPRESENTATION IN COMPETITION WITH WT CELLS IN THE SAME HOST.FOR AIM 3, WE CONTINUE TO EVALUATE GPR25 EXPRESSION IN HUMAN AND MOUSE DISEASE MODELS (SCRNA SEQ DATA TO DATE FROM PUBLIC RESOURCES). WE ARE INTERESTED IN GWAS ASSOCIATIONS OF GPR25 WITH ARTERIAL STIFFNESS: WE SEE SIGNIFICANT T CELL SUBSET EXPRESSION OF GPR25 IN DATA FROM HUMAN CORONARY ARTERY DISEASE. WE ARE ALSO INTERESTED IN UNDERSTANDING THE GWAS ASSOCIATIONS OF HUMAN BLOOD GPR25 WITH AUTOIMMUNE DISEASES ESPECIALLY IBD: THROUGH COLLABORATION WITH DR. MONTGOMERY, COLOCALIZATION ANALYSIS INDICATE THAT GPR25 HAS THE HIGHEST PP4 AMONG GENES IN THE REGION FOR IBD, CROHN'S DISEASE, AND ULCERATIVE COLITIS, PRIORITIZING GPR25 AS THE LIKELY CAUSAL GENE AT THIS LOCUS. WE HAVE PERFORMED RNA SCOPE ON INTESTINAL SAMPLES FROM IBD PATIENTS (WITH OUR COLLABORATOR AND CO-INVESTIGATOR SERENA TAN) REVEALING STRONG CXCL17 EXPRESSION WITHIN SITES OF PYLORIC METAPLASIA CONSISTENT WITH SINGLE-CELL RNA-SEQ DATA AND SUPPORTING RECRUITMENT OF GPR25 IMMUNE CELLS TO INFLAMED MUCOSA. RECRUITMENT OF GPR25+ TREGS COULD EXPLAIN THE ROLE OF HIGHER PBMC GPR25 IN REDUCING IBD. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,062,166 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | ALL OF US RESEARCH PROGRAM. PRINCIPAL INVESTIGATORS: PHILIP TSAO, PH.D. THE ALL OF US RESEARCH PROGRAM (ALL OF US) IS A LARGE COLLABORATIVE INITIATIVE SPONSORED BY THE NATIONAL INSTITUTES OF HEALTH (NIH). ALL OF US INCLUDES A CONSORTIUM OF AWARDEES FROM MULTIPLE INSTITUTIONS, INCLUDING THE DEPARTMENT OF VETERANS AFFAIRS. ALL OF US IS WORKING TO IMPROVE HEALTHCARE THROUGH RESEARCH BY BUILDING A DIVERSE DATABASE OF PARTICIPANT SELF-REPORT INFORMATION, BIOSPECIMENS, AND ELECTRONIC HEALTH RECORDS THAT CAN INFORM FUTURE RESEARCH ON A VARIETY OF HEALTH CONDITIONS. VA PARTICIPATION IN ALL OF US IS OVERSEEN BY TWO CO-PIS, LOCATED AT THE VA PALO ALTO HEALTHCARE SYSTEM AND THE VA BOSTON HEALTHCARE SYSTEM. THESE TWO INSTITUTIONS SERVE AS THE COORDINATING CENTERS FOR VA RESPONSIBLE FOR CENTRALIZED RECRUITMENT, ENGAGEMENT CAMPAIGNS, AND COMPLIANCE WITH PROGRAM REQUIREMENTS. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $24,180,777 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $10,144,436 | RevenueAmt |
| Desc | PAVIR IS PRIVILEGED TO WORK WITH A LARGE COMMUNITY OF UNIQUELY TALENTED MEDICAL RESEARCHERS ACROSS A BROAD SPECTRUM OF RESEARCH AREAS AS WE FULFILL OUR MISSION OF ADVANCING VETERANS AND PUBLIC HEALTH THROUGH INNOVATIVE RESEARCH. THE RANGE OF RESEARCH ACTIVITIES IS BROAD AND INCLUDES SPECIAL EMPHASIS ON MAJOR DISEASE CATEGORIES, ALL OF WHICH ARE PREVALENT IN THE VA'S PATIENT POPULATION. THESE INCLUDE CARDIOVASCULAR MEDICINE, MENTAL HEALTH, CHRONIC INFLAMMATORY DISEASE, STEM CELL/REGENERATIVE MEDICINE, PAIN, SLEEP DISORDERS, AND MANY OTHERS. IN ADDITION TO DISEASE SPECIFIC RESEARCH, PAVIR IS ENGAGED IN SUPPORTING RESEARCH AIMED AT ENHANCING HEALTH CARE. PAVIR'S RESEARCH PORTFOLIO INCLUDES COMPARATIVE STUDIES IN WHICH RESEARCH TEAMS ARE LEARNING WHICH TREATMENTS ARE SUPERIOR TO OTHERS, HOW TO AUGMENT OR IMPROVE STANDARD OF CARE, AS WELL AS HOW TO ENHANCE THE OPERATION OF HEALTH CARE. FURTHERMORE, PAVIR IS SUPPORTING EDUCATIONAL ACTIVITIES, ESPECIALLY IN AREAS OF ADVANCING CLINICAL CARE FOR VETERANS AND FOSTERING THE PROFESSIONAL DEVELOPMENT OF OUR EXPERT STAFF. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $24,180,777 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $0 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $10,144,436 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $27,791,858 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 48 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 203 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 13 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 3 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (1) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JENNY DAO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 6502392822 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3801 MIRANDA AVENUE | AddressLine1Txt |
| City | PALO ALTO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94304 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (25 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| ODETTE HARRIS | |||||||||
| DIRECTOR / BOARD CHAIR | 1.00 | 40.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| PAUL HEIDENREICH | |||||||||
| DIRECTOR / SECRETARY & TREASURER | 0.50 | 40.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| MAHEEN ADAMSON | |||||||||
| DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| JON FULLER | |||||||||
| STATUTORY VA DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| JEAN GURGA | |||||||||
| STATUTORY VA DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| NGAN HUANG | |||||||||
| DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| MEGHAN KEMNEC | |||||||||
| STATUTORY NON-VA DIRECTOR | 0.50 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| MIKE KOZAL | |||||||||
| STATUTORY VA DIRECTOR (THRU 10/2024) | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| WARE KUSCHNER | |||||||||
| DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| JENNIFER LEE | |||||||||
| STATUTORY VA DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| LAWRENCE LEUNG | |||||||||
| DIRECTOR / AUDIT COMMITTEE CHAIR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| PAYAM MASSABAND | |||||||||
| STATUTORY VA DIRECTOR | 0.50 | 40.00 | Yes (X) | $0 | $0 | $0 | |||
| VANESSA RIDLEY | |||||||||
| DIRECTOR | 0.50 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| ROBERT SLOSS | |||||||||
| STATUTORY NON-VA DIRECTOR | 0.50 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| ELAINE STAATS | |||||||||
| CHIEF EXECUTIVE OFFICER | 40.00 | 0.00 | Yes (X) | $282,965 | $0 | $63,244 | |||
| LILY IBRAGIMOV | |||||||||
| DIRECTOR OF FINANCE & ACCOUNTING | 40.00 | 0.00 | Yes (X) | $185,095 | $0 | $31,098 | |||
| MARY THORNTON | |||||||||
| DIRECTOR OF OPERATIONS | 40.00 | 0.00 | $194,444 | $0 | $32,397 | Yes (X) | |||
| ALLISON MALATE | |||||||||
| DIRECTOR OF SPONSORED RESEARCH | 40.00 | 0.00 | $190,624 | $0 | $31,382 | Yes (X) | |||
| LISA CLARK | |||||||||
| DIRECTOR OF HUMAN RESOURCES | 40.00 | 0.00 | $197,306 | $0 | $18,452 | Yes (X) | |||
| NORA THOMAS | |||||||||
| HUMAN RESOURCES MANAGER | 40.00 | 0.00 | $151,316 | $0 | $27,396 | Yes (X) | |||
| TIMOTHY MYLES | |||||||||
| RESEARCH SCIENTIST III | 40.00 | 0.00 | $185,636 | $0 | $41,718 | Yes (X) | |||
| XINGUO JIANG | |||||||||
| RESEARCH SCIENTIST II | 40.00 | 0.00 | $160,856 | $0 | $41,247 | Yes (X) | |||
| CALVERT LEE | |||||||||
| SR. CLINICAL RESEARCH MANAGER | 40.00 | 0.00 | $155,791 | $0 | $41,464 | Yes (X) | |||
| STEPHANIE HENSEY | |||||||||
| DEVELOPER / DATABASE ADMINISTRATOR | 40.00 | 0.00 | $158,718 | $0 | $26,314 | Yes (X) | |||
| JIAN LUO | |||||||||
| RESEARCH SCIENTIST III | 40.00 | 0.00 | $158,648 | $0 | $14,685 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,021,399 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $369,397 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 42 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $21,268,425 | GovernmentGrantsAmt |
| All Other Contributions | $4,049,876 | AllOtherContributionsAmt |
| Total Contributions | $25,318,301 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| MEDICAL RESEARCH | 541700 | $5,150,942 | $5,150,942 |
| PERSONNEL REIMBURSEMENTS - VAPAHC | 541700 | $4,279,767 | $4,279,767 |
| GOVERNMENT FEES & CONTRACTS | 541700 | $713,727 | $713,727 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $10,144,436 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $367,884 | TotalRevenueColumnAmt |
| Exclusion | $367,884 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | MISCELLANEOUS INCOME | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $23,510 | TotalRevenueColumnAmt |
| Exclusion | $23,510 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $23,510 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $35,854,131 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $10,144,436 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $391,394 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,480,336 | TotalAmt |
| Management And General | $1,480,336 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,241,584 | TotalAmt |
| Program Services | $11,836,977 | ProgramServicesAmt |
| Management And General | $2,404,607 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,008,277 | TotalAmt |
| Program Services | $826,625 | ProgramServicesAmt |
| Management And General | $181,652 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,902,193 | TotalAmt |
| Program Services | $1,550,405 | ProgramServicesAmt |
| Management And General | $351,788 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,183,323 | TotalAmt |
| Program Services | $912,057 | ProgramServicesAmt |
| Management And General | $271,266 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40,187 | TotalAmt |
| Program Services | $25,014 | ProgramServicesAmt |
| Management And General | $15,173 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $75,870 | TotalAmt |
| Management And General | $75,870 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,050,394 | TotalAmt |
| Program Services | $4,959,741 | ProgramServicesAmt |
| Management And General | $90,653 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $126,145 | TotalAmt |
| Program Services | $115,281 | ProgramServicesAmt |
| Management And General | $10,864 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $363,888 | TotalAmt |
| Program Services | $167,300 | ProgramServicesAmt |
| Management And General | $196,588 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $352,491 | TotalAmt |
| Program Services | $339,328 | ProgramServicesAmt |
| Management And General | $13,163 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $125,574 | TotalAmt |
| Program Services | $94,449 | ProgramServicesAmt |
| Management And General | $31,125 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $221,702 | TotalAmt |
| Program Services | $221,702 | ProgramServicesAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $83,527 | TotalAmt |
| Management And General | $83,527 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| SUBRECIPIENTS | $4,387,176 | $4,387,176 | |
| RESEARCH MATERIAL COST | $2,164,917 | $2,164,730 | $187 |
| EQUIPMENT MAINTENANCE | $48,227 | $48,227 | |
| OTHER PERSONNEL COST | $18,026 | $18,026 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $155,551 | TotalAmt |
| Program Services | $142,846 | ProgramServicesAmt |
| Management And General | $12,705 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,029,388 | TotalAmt |
| Program Services | $27,791,858 | ProgramServicesAmt |
| Management And General | $5,237,530 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,531,128 | BOYAmt |
| EOY | $3,218,894 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,881,528 | BOYAmt |
| EOY | $11,100,159 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,910,131 | BOYAmt |
| EOY | $3,075,804 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $104,137 | BOYAmt |
| EOY | $131,161 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $4,166,239 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $3,319,849 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $759,833 | BOYAmt |
| EOY | $846,390 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,059,432 | BOYAmt |
| EOY | $774,243 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $17,246,189 | BOYAmt |
| EOY | $19,146,651 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,533,705 | BOYAmt |
| EOY | $4,202,472 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,496,445 | BOYAmt |
| EOY | $6,854,597 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $52,549 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,030,150 | BOYAmt |
| EOY | $11,109,618 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,883,176 | BOYAmt |
| EOY | $8,015,245 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $332,863 | BOYAmt |
| EOY | $21,788 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,216,039 | BOYAmt |
| EOY | $8,037,033 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $17,246,189 | BOYAmt |
| EOY | $19,146,651 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $2,824,743 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $11,777 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$15,526 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp
Supported Organization Name SupportedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VA PALO ALTO HEALTH CARE SYSTEM | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | PALO ALTO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $4,166,239 | OtherCostOrOtherBasisAmt |
| Depreciation | $3,319,849 | DepreciationAmt |
| Book Value | $846,390 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $846,390 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | DUE TO VAPAHCS | Desc |
| Amt | $52,549 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $52,549 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $35,850,382 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $11,777 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$15,526 | OtherRevenueAmt |
| Revenue Not Reported | -$3,749 | RevenueNotReportedAmt |
| Revenue Subtotal | $35,854,131 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $35,854,131 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $33,029,388 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $33,029,388 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $33,029,388 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART X, LINE 2: | THE ORGANIZATION OPERATES AS A NONPROFIT ORGANIZATION AND HAS BEEN NOTIFIED BY THE TAXING AUTHORITIES THAT IT IS EXEMPT FROM FEDERAL INCOME AND STATE FRANCHISE TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND SECTION 23701D OF THE REVENUE AND TAXATION CODE OF THE STATE OF CALIFORNIA, RESPECTIVELY. THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER IRC SECTION 170(B)(1)(A)(III) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 509(A)(1). THE ORGANIZATION FILES EXEMPT ORGANIZATION RETURNS AND, IF APPLICABLE, UNRELATED BUSINESS INCOME TAX RETURNS IN THE U.S. FEDERAL AND CALIFORNIA JURISDICTIONS. THERE IS NO UNRELATED BUSINESS INCOME TAX FOR THE YEARS ENDED SEPTEMBER 30, 2025 AND 2024. ACCORDINGLY, NO PROVISION FOR INCOME TAXES IS INCLUDED IN THE FINANCIAL STATEMENTS. THE ORGANIZATION HAD NO UNRECOGNIZED TAX BENEFITS AT SEPTEMBER 30, 2025 AND 2024. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | RETURNED CONTRIBUTIONS -15,526. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELAINE STAATS | ||||||||||||||
| CHIEF EXECUTIVE OFFICER | $282,965 | $0 | $0 | $0 | $0 | $0 | $26,526 | $0 | $36,718 | $0 | $346,209 | $0 | $0 | $0 |
| TIMOTHY MYLES | ||||||||||||||
| RESEARCH SCIENTIST III | $185,636 | $0 | $0 | $0 | $0 | $0 | $5,000 | $0 | $36,718 | $0 | $227,354 | $0 | $0 | $0 |
| MARY THORNTON | ||||||||||||||
| DIRECTOR OF OPERATIONS | $194,444 | $0 | $0 | $0 | $0 | $0 | $17,942 | $0 | $14,455 | $0 | $226,841 | $0 | $0 | $0 |
| ALLISON MALATE | ||||||||||||||
| DIRECTOR OF SPONSORED RESEARCH | $190,624 | $0 | $0 | $0 | $0 | $0 | $17,282 | $0 | $14,100 | $0 | $222,006 | $0 | $0 | $0 |
| LILY IBRAGIMOV | ||||||||||||||
| DIRECTOR OF FINANCE & ACCOUNTING | $185,095 | $0 | $0 | $0 | $0 | $0 | $16,606 | $0 | $14,492 | $0 | $216,193 | $0 | $0 | $0 |
| LISA CLARK | ||||||||||||||
| DIRECTOR OF HUMAN RESOURCES | $197,306 | $0 | $0 | $0 | $0 | $0 | $18,062 | $0 | $390 | $0 | $215,758 | $0 | $0 | $0 |
| XINGUO JIANG | ||||||||||||||
| RESEARCH SCIENTIST II | $160,856 | $0 | $0 | $0 | $0 | $0 | $15,124 | $0 | $26,123 | $0 | $202,103 | $0 | $0 | $0 |
| CALVERT LEE | ||||||||||||||
| SR. CLINICAL RESEARCH MANAGER | $155,695 | $0 | $96 | $0 | $0 | $0 | $14,667 | $0 | $26,797 | $0 | $197,255 | $0 | $0 | $0 |
| STEPHANIE HENSEY | ||||||||||||||
| DEVELOPER / DATABASE ADMINISTRATOR | $158,718 | $0 | $0 | $0 | $0 | $0 | $14,504 | $0 | $11,810 | $0 | $185,032 | $0 | $0 | $0 |
| NORA THOMAS | ||||||||||||||
| HUMAN RESOURCES MANAGER | $151,316 | $0 | $0 | $0 | $0 | $0 | $14,070 | $0 | $13,326 | $0 | $178,712 | $0 | $0 | $0 |
| JIAN LUO | ||||||||||||||
| RESEARCH SCIENTIST III | $158,648 | $0 | $0 | $0 | $0 | $0 | $14,295 | $0 | $390 | $0 | $173,333 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FORM 990, PART VII AND SCHEDULE J, PART II: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION WROTE TO EACH MEMBER OF THE BOARD OF DIRECTORS WHO WAS COMPENSATED BY THE VA PALO HEALTH CARE SYSTEM REQUESTING PERMISSION TO OBTAIN HIS/HER COMPENSATION INFORMATION FOR THE CALENDAR YEAR ENDED DECEMBER 31, 2024. ALL MEMBERS DECLINED IN WRITING TO PROVIDE THEIR COMPENSATION INFORMATION. NONE OF THE BOARD MEMBERS RECEIVED COMPENSATION IN RELATION TO THEIR DUTIES AS BOARD MEMBERS OF PAVIR. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 7A | PAVIR IS A NONPROFIT CORPORATION AUTHORIZED BY TITLE 38 US CODE SECTIONS 7361 THROUGH 7366 TO BE ESTABLISHED AND AFFILIATED WITH THE DEPARTMENT OF VETERANS AFFAIRS PALO ALTO HEALTH CARE SYSTEM (VAPAHCS). THE REFERENCED STATUTE DICTATES THAT FOUR DIRECTORS SHALL BE THOSE PERSONS HOLDING THE VAPAHCS POSITIONS OF DIRECTOR, CHIEF OF STAFF, ASSOCIATE CHIEF OF STAFF FOR RESEARCH, AND ASSOCIATE CHIEF OF STAFF FOR EDUCATION ("VA STATUTORY DIRECTORS"). FURTHER, ONE OF THE "NON-STATUTORY DIRECTORS" AUTOMATICALLY SHALL BE THE CHAIR OF THE VAPAHCS RESEARCH AND DEVELOPMENT COMMITTEE BY VIRTUE OF HIS OR HER POSITION AS COMMITTEE CHAIR AND ANOTHER "NON-STATUTORY DIRECTOR" SHALL AUTOMATICALLY BE THE CHAIR OF THE ADVISORY RESEARCH COMMITTEE BY VIRTUE OF HIS OR HER POSITION AS COMMITTEE CHAIR. |
| FORM 990, PART VI, SECTION A, LINE 7B | THE U.S. DEPARTMENT OF VETERANS AFFAIRS HAS THE AUTHORITY TO IMPOSE REQUIREMENTS AND RESTRICTIONS ON THE ORGANIZATION UNDER TITLE 38 US CODE SECTIONS 7361 THROUGH 7366. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PREPARED BY AN INDEPENDENT TAX ACCOUNTANT IN CONJUNCTION WITH THE ORGANIZATION'S ACCOUNTING AND FINANCE DEPARTMENT AND REVIEWED BY MANAGEMENT; ADJUSTMENTS ARE MADE, AS NECESSARY. A COMPLETE COPY OF THE FORM 990 IS THEN PROVIDED TO ALL VOTING MEMBERS OF THE GOVERNING BODY PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WHICH COVERS EACH VOTING MEMBER OF THE GOVERNING BODY, OFFICER, AND KEY EMPLOYEE WHICH REQUIRES SUCH INDIVIDUALS TO COMPLETE A "DISCLOSURE QUESTIONNAIRE AND AFFIRMATION OF COMPLIANCE" UPON INITIATING THEIR ASSOCIATION WITH PAVIR AS WELL AS ANY TIME A CHANGE IN THEIR CIRCUMSTANCES MAY RESULT IN A POTENTIAL CONFLICT OF INTEREST OR ANNUALLY (WHICHEVER OCCURS FIRST); THESE QUESTIONNAIRES ARE SUBMITTED TO THE CHIEF EXECUTIVE OFFICER AND PROVIDED TO THE BOARD WILL REVIEW. THE BOARD THEN DECIDES WHETHER ANY DISCLOSURES REPRESENT ACTUAL, PERCEIVED, OR POTENTIAL CONFLICTS OF INTEREST. DISINTERESTED MEMBERS OF THE BOARD VOTE ON THE PROPOSED TRANSACTION OR ARRANGEMENT WHICH MIGHT GIVE RISE TO A CONFLICT; ANY CONFLICTED INDIVIDUAL DOES NOT ANTICIPATE IN ANY IN, OR BE PRESENT DURING, THE DELIBERATIONS AND DECISION-MAKING VOTE OF PAVIR WITH RESPECT TO SUCH MATTER. |
| FORM 990, PART VI, SECTION B, LINE 15 | ANNUALLY, PAVIR COLLECTS AND ANALYZES MARKET, SALARY SURVEY AND COMPENSATION STUDY DATA BASED ON COMPARABLE INDUSTRY AND REVENUE. THE BOARD'S COMPENSATION COMMITTEE REVIEWS THE DATA, TAKING INTO ACCOUNT PERFORMANCE AND ACCOMPLISHMENTS WHEN ESTABLISHING THE CEO'S COMPENSATION. THE COMPENSATION COMMITTEE KEEPS MINUTES OF ITS MEETINGS AND REPORTS ITS ACTIONS TO THE FULL BOARD. KEY EMPLOYEES' SALARIES ARE SET BY THE CEO UTILIZING INFORMATION FROM PAVIR'S ANNUAL SALARY SCHEDULES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. ADDITIONALLY, THE MOST RECENT AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON PAVIR'S WEBSITE. |
| FORM 990, PART IX, LINE 11G | OTHER FEES FOR SERVICES: PROGRAM SERVICE EXPENSES 4,959,741. MANAGEMENT AND GENERAL EXPENSES 90,653. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,050,394. |
| FORM 990, PART XI, LINE 9: | RETURNED CONTRIBUTIONS -15,526. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VA PALO ALTO HEALTH CARE SYSTEM | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3801 MIRANDA AVE | AddressLine1Txt |
| City | PALO ALTO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94304 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 941179505 | EIN |
| Primary Activities | TEACHING HOSPITAL, PROVIDING A FULL RANGE OF PATIENT CARE SERVICES | PrimaryActivitiesTxt |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |